Evoq Remedies Profit & Loss Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs
4.78 +0.09 (1.92%)Updated : 16 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 11.764.0520.3916.78
Total Revenue 11.764.0520.3916.78
Costof Revenue Total 13.081.5619.3313.77
Gross Profit -1.322.501.063.01
Selling/ General/ Admin Expenses Total 0.070.080.200.18
Depreciation/ Amortization 0.050.010.000.00
Other Operating Expenses Total 0.844.064.591.37
Total Operating Expense 14.045.7024.1315.32
Operating Income -2.29-1.65-3.741.46
Interest Inc( Exp) Net- Non- Op Total 0.00--0.00
Other Net 2.412.266.020.00
Net Income Before Taxes 0.130.612.281.46
Provisionfor Income Taxes 0.040.160.670.37
Net Income After Taxes 0.090.451.621.09
Net Income Before Extra Items 0.090.451.621.09
Net Income 0.090.451.621.09
Income Availableto Com Excl Extra Ord 0.090.451.621.09
Income Availableto Com Incl Extra Ord 0.090.451.621.09
Diluted Net Income 0.090.451.621.09
Diluted Weighted Average Shares 2.211.361.361.36
Diluted EPS Excluding Extra Ord Items 0.040.331.190.80
Diluted Normalized EPS 0.040.331.190.80
period Length 12.0012.0012.0012.00
period Type ----
Total Adjustmentsto Net Income ---0.00
DPS- Common Stock Primary Issue ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
11,489.00+268.30(2.39%)
1,694.10+35.15(2.12%)
1,723.05+28.20(1.66%)
686.70-25.35 (-3.56%)